GENE ONLINE|News &
Opinion
Blog

Flagship Pioneering
Tessera Therapeutics Partners with Cystic Fibrosis Foundation to Treat Life-Threatening Disease with Gene Writers
2021-11-05
Laronde Bags $440 M in Series B to Advance Novel Medicines Using endless RNA Technology
2021-08-30
Laronde Launches to Disrupt the Industry with Programmable Circular RNA Therapies
2021-05-15
Flagship Pioneering Unveils AI Driven Drug Discovery Start-Up
2020-09-28
Tessera Therapeutics Aims to Rewrite DNA with New Age Gene Manipulators
2020-07-10
LATEST
Biogen’s Tofersen May Show Clinical Benefit in ALS Patients with Rare SOD1 Mutations
2023-03-21
Comparing ESG Regulations in the U.S., the U.K., and the EU
2023-03-21
See-Mode Technologies Secures Regulatory Approvals for its AI-powered Software that Automatically Analyses and Reports Breast & Thyroid Ultrasound Scans in Australia and New Zealand
2023-03-21
OncoC4 Bags $200 Million In CTLA-4 Antibody Pact With BioNTech
2023-03-21
HHS Issues Initial Guidance on Negotiation Program as Government’s Latest Move to Reduce Drug Prices
2023-03-21
First-Ever Insect Brain Neuron Map Completed
2023-03-21
AbbVie Unveils Latest Data For Skyrizi In Difficult-To-Treat Psoriasis
2023-03-20
Scroll to Top